Increased FFA levels promote muscle and liver insulin resistance (IR), impair insulin secretion from pancreatic β cells, attenuate glucose uptake in skeletal muscle and liver cells, increase hepatic glucose production, and decrease hepatic glycogen synthesis, ultimately leading to chronic hyperglycaemia [5]. The gene discussed is INS; the disease is Hyperglycemia.